Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an anti-staphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: pre-planned analysis from CAMERA2 [0.03%]
万古霉素或达托霉素联合抗葡萄球菌青霉素类药物治疗耐甲氧西林金黄色葡萄球菌败血症的体外协同作用和相加作用对CAMERA2研究中患者死亡率的影响：预先计划的分析
Joel Z Y Soo,Tze-Peng Lim,Jayden J Y Ho et al.
Joel Z Y Soo et al.
Objective: Combination antibiotic therapy may improve treatment success for bacterial infections, but bacterial strain-to-strain variability in synergy and its clinical impact remains unclear. This study evaluated whether...
Which trials do we need? The never-ending quest for an oral switch regimen in culture-negative prosthetic valve infective endocarditis [0.03%]
何去何从？求索人工瓣膜感染性心内膜炎口服序贯治疗的未解之路
Giuseppe Pipitone,Guido Granata,Alberto Enrico Maraolo
Giuseppe Pipitone
Resistance development to new anti-gram negatives during treatment: geographical epidemiology and risk factors [0.03%]
治疗过程中针对新型抗革兰氏阴性菌药物的耐药性发展：地理流行病学和风险因素
Marco Falcone,Giusy Tiseo,Ryan K Shields
Marco Falcone
Background: Treatment-emergent resistance is increasingly reported in carbapenem-resistant Enterobacterales (CRE) during therapy with newly developed antibioticss. However, standardized definitions and studies evaluating ...
'Estimating antibiotic resistance following antibiotic treatment in outpatients' - Author's reply [0.03%]
“估计门诊患者抗生素治疗后的耐药率”——作者回应
Michal Chowers,Dor Atias,Uri Obolski
Michal Chowers
Which trial do we need? Defining the optimal duration of antifungal therapy for invasive pulmonary aspergillosis: duration of therapy in invasive aspergillosis [0.03%]
我们需要哪种临床试验？确定侵袭性肺曲霉病抗真菌治疗疗程：侵袭性曲霉病的治疗期限
Guillaume Desoubeaux,Malgorzata Mikulska,Adrien Lemaignen et al.
Guillaume Desoubeaux et al.
Genomic determinants of Bacillus cereus and outcomes of infection in preterm neonates: a multicentre retrospective study [0.03%]
芽胞杆菌基因组决定因素与早产儿感染结局的多中心回顾性研究
Alicia Chevalier,Mariem Ben Khedher,Antoine Tran et al.
Alicia Chevalier et al.
Objectives: Bacillus cereus sensu lato (s.l.) or B. cereus group increasingly causes severe infections in preterm neonates. However, species-level identification and virulence characterization remain limited. This study a...
Neisseria meningitidis MenY ST-1466 Harbouring N. gonorrhoeae 16S rRNA Allele Causing False-Positive Aptima® Gonococcal NAAT Results [0.03%]
淋病奈瑟球菌16S rRNA基因变异致脑膜炎奈瑟球菌阳性误判的假阴性样本报道
S J van Hal,E Goeman,Y Davidson et al.
S J van Hal et al.
María Paniagua-García,Ana Caro-Leiro,María José Gómez-Gómez et al.
María Paniagua-García et al.
The path ahead: Building community between palliative care and infectious disease teams [0.03%]
未来之路：缓和医疗团队与传染病团队之间的社区建设
Daniel Karlin,Tara Vijayan
Daniel Karlin
Nationwide emergence of cefotaxime-resistant Neisseria meningitidis via interspecies gene transfer from penA795-bearing Neisseria commensals in China [0.03%]
中国耐头孢曲松脑膜炎奈瑟菌的全国性流行是由于携带penA795等位基因的共生菌间的基因转移所致
Youxing Shao,Xin Lan,Mingliang Chen et al.
Youxing Shao et al.